Sanlam Limited:企業の戦略・SWOT・財務情報

◆英語タイトル:Sanlam Limited - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C5624
◆発行会社(調査会社):MarketLine
◆発行日:2018年10月
◆ページ数:44
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:南アフリカ
◆産業分野:サービス
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Sanlam Limited – Strategy, SWOT and Corporate Finance Report
Summary

Sanlam Limited – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Sanlam Limited (Sanlam) is a provider of financial services. The company, through its subsidiaries, offers personal, business and institutional financial solutions. Its financial solutions include life insurance, general insurance, and investment management including asset management, retail savings and wealth management, credit and structuring, retirement fund administration, health and other services such as estate planning, wills, trusts, unsecured lending and health management. Sanlam also provides financial planning and electronic financial transaction services. The company offers these services to individuals, corporate customers and institutions. Its operations are spanned across South Africa, the UK, India, Australia, Malaysia and the US markets. Sanlam is headquartered in Bellville, South Africa.

The company reported gross written premium of ZAR25, 909 million during the fiscal year 2016 (FY2016), representing an increase of 6.5% over FY2015. Its net earned premium was ZAR19, 826 million in FY2016, an increase of 7% over FY2015.

Scope

- Detailed information on Sanlam Limited required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Sanlam Limited in the form of a SWOT analysis
- An in-depth view of the business model of Sanlam Limited including a breakdown and examination of key business segments
- Intelligence on Sanlam Limited’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Sanlam Limited, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Sanlam Limited and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Sanlam Limited as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Sanlam Limited’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
Sanlam Limited: Company Overview 9
Sanlam Limited: Overview and Key Facts 9
Sanlam Limited: Overview 9
Sanlam Limited: Key Facts 9
Sanlam Limited: Key Employees 10
Sanlam Limited: Key Employee Biographies 12
Sanlam Limited: Major Products and Services 13
Sanlam Limited: Company History 14
Sanlam Limited: Management Statement 17
Sanlam Limited: Locations and Subsidiaries 22
Sanlam Limited: Key Competitors 23
Sanlam Limited: Company Analysis 24
Sanlam Limited: Business Description 24
Sanlam Limited: SWOT Analysis 26
Sanlam Limited: SWOT Overview 26
Sanlam Limited: Strengths 26
Sanlam Limited: Weaknesses 27
Sanlam Limited: Opportunities 27
Sanlam Limited: Threats 28
Sanlam Limited: Corporate Financial Deals Activity 29
Sanlam Limited: Financial Deals Overview 29
Sanlam Limited: Targets and Partners 31
Sanlam Limited: Top Deals 2014 – 2018YTD* 32
Sanlam Limited: Mergers and Acquisitions 33
Sanlam Limited: Divestments 34
Sanlam Limited: Recent Developments 35
Sanlam Limited: News and Events Summary 35
Sanlam Limited: Business Expansion 38
Sanlam Limited: Contracts 38
Sanlam Limited: Corporate Governance 39
Sanlam Limited: Financial Deals 40
Sanlam Limited: Financial Performance 40
Sanlam Limited: Market Developments 41
Sanlam Limited: Strategy and Operations 41
Appendix 42
Contact Us 42
Methodology 42
About MarketLine 43

List of Tables
Table 1: Sanlam Limited: Key Facts
Table 2: Sanlam Limited: Key Employees
Table 3: Sanlam Limited: Company History
Table 4: Sanlam Limited: Locations and Subsidiaries
Table 5: Sanlam Limited: Key Competitors
Table 6: Sanlam Limited: Deal Activity by Deal Type - Volume (TTM*)
Table 7: Sanlam Limited: M&A Activity by Geography (TTM*)
Table 8: Sanlam Limited: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 9: Sanlam Limited: M&A Average Deal Size - Value (US$m)
Table 10: Sanlam Limited: Targets and Partners
Table 11: Sanlam Limited: Top Deals 2014 - 2018YTD*
Table 12: Sanlam Limited: M&A Volume and Value Trend (2014 - YTD*2018)
Table 13: Sanlam Limited: M&A Activity by Geography (2014 - YTD*2018)
Table 14: Sanlam Limited: Divestments Volume and Value Trend (2014 - YTD*2018)
Table 15: Sanlam Limited: News and Events Summary
Table 16: Sanlam Limited: Business Expansion
Table 17: Sanlam Limited: Contracts
Table 18: Sanlam Limited: Corporate Governance
Table 19: Sanlam Limited: Financial Deals
Table 20: Sanlam Limited: Financial Performance
Table 21: Sanlam Limited: Market Developments
Table 22: Sanlam Limited: Strategy and Operations

List of Figures
Figure 1: Sanlam Limited: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Sanlam Limited: M&A Activity by Geography (TTM*)
Figure 3: Sanlam Limited: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 4: Sanlam Limited: M&A Average Deal Size - Value (US$m)
Figure 5: Sanlam Limited: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 6: Sanlam Limited: M&A Activity by Geography (2014 - YTD*2018)
Figure 7: Sanlam Limited: Divestments Volume and Value Trend (2014 - YTD*2018)

★海外企業調査レポート[Sanlam Limited:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Yokogawa Electric Corporation:企業の戦略・SWOT・財務情報
    Yokogawa Electric Corporation - Strategy, SWOT and Corporate Finance Report Summary Yokogawa Electric Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Fidelity Life Assurance of Zimbabwe Ltd:企業の戦略・SWOT・財務情報
    Fidelity Life Assurance of Zimbabwe Ltd - Strategy, SWOT and Corporate Finance Report Summary Fidelity Life Assurance of Zimbabwe Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • Magellan Midstream Partners LP (MMP):企業の財務・戦略的SWOT分析
    Magellan Midstream Partners LP (MMP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Thermax Ltd (THERMAX):企業の財務・戦略的SWOT分析
    Thermax Ltd (THERMAX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Baxter International Inc.:企業のM&A・事業提携・投資動向
    Baxter International Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Baxter International Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisi …
  • Tasly Pharmaceutical Group Co Ltd (600535):企業の財務・戦略的SWOT分析
    Tasly Pharmaceutical Group Co Ltd (600535) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengt …
  • Japan Pulp and Paper Co Ltd:戦略・SWOT・企業財務分析
    Japan Pulp and Paper Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Japan Pulp and Paper Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Horizon Therapeutics Plc (HZNP):企業の財務・戦略的SWOT分析
    Horizon Therapeutics Plc (HZNP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Bawag Psk:企業の戦略・SWOT・財務分析
    Bawag Psk - Strategy, SWOT and Corporate Finance Report Summary Bawag Psk - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Purdue Pharma Canada:製薬・医療:M&Aディール及び事業提携情報
    Summary Purdue Pharma Canada, a subsidiary of Purdue Pharma LP is a research-based pharmaceutical company that offers services such as development, manufacturing and commercialization of medicines for patients and healthcare professionals. The company portfolio of products includes antiseptics, laxa …
  • SRT Marine Systems plc (SRT):企業の財務・戦略的SWOT分析
    SRT Marine Systems plc (SRT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • AGL Energy Limited:企業の戦略・SWOT・財務分析
    AGL Energy Limited - Strategy, SWOT and Corporate Finance Report Summary AGL Energy Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • SRI International-医療機器分野:企業M&A・提携分析
    Summary SRI International (SRI) is a research institute which provides commercial research and development programs. It conducts research and development in the areas of biosciences, health and medical systems, chemistry and materials, communications and networks, computing, earth and space, economi …
  • Supervalu Inc (SVU):企業の財務・戦略的SWOT分析
    Supervalu Inc (SVU) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Faron Pharmaceuticals Oy (FARN)-医療機器分野:企業M&A・提携分析
    Summary Faron Pharmaceuticals Oy (Faron Pharma) is a drug company that carries out clinical stage drug discovery and development. The company's product portfolio includes traumakine; clevegen; farbetic, an AOC3 inhibitor and D-ARDS, a diagnostic tool. Its traumakine clinical programme manages the tr …
  • Mirvac Group:企業の戦略・SWOT・財務情報
    Mirvac Group - Strategy, SWOT and Corporate Finance Report Summary Mirvac Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Phio Pharmaceuticals Corp (RXII):企業の財務・戦略的SWOT分析
    Summary Phio Pharmaceuticals Corp (Phio Pharmaceuticals), formerly known as RXi Pharmaceuticals Corp, is a biotechnology company. It discovers, develops and commercializes immuno-oncology therapeutics based RNAi platform to treat cancer. Its product pipeline includes PH-762, PH-894 and PH-804 for ad …
  • Biofrontera AG (B8F):企業の財務・戦略的SWOT分析
    Biofrontera AG (B8F) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • The Tata Power Co Ltd (TATAPOWER):企業の財務・戦略的SWOT分析
    The Tata Power Co Ltd (TATAPOWER) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Enusa Industrias Avanzadas, S.A., S.M.E:企業の戦略的SWOT分析
    Enusa Industrias Avanzadas, S.A., S.M.E - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and m …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆